These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Safety, efficacy, and mid-term oncological outcomes of computed tomography-guided cryoablation of T1 renal cancer. Duus LA; Junker T; Rasmussen BS; Bojsen JA; Pedersen AL; Anthonsen A; Lund L; Pedersen M; Graumann O Acta Radiol; 2023 Feb; 64(2):814-820. PubMed ID: 35297745 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous cryoablation for renal cell carcinoma using ultrasound-guided targeting and computed tomography-guided ice-ball monitoring: radiation dose and short-term outcomes. Kim DK; Won JY; Park SY Acta Radiol; 2019 Jun; 60(6):798-804. PubMed ID: 30149751 [TBL] [Abstract][Full Text] [Related]
16. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma. Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794 [TBL] [Abstract][Full Text] [Related]
17. Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers. De Marini P; Cazzato RL; Garnon J; Dalili D; Leonard-Lorant I; Leclerc L; Autrusseau PA; Auloge P; Weiss J; Tricard T; Lang H; Gangi A Diagn Interv Imaging; 2021 Sep; 102(9):531-538. PubMed ID: 33931365 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift? Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831 [TBL] [Abstract][Full Text] [Related]